methylprednisolone has been researched along with Anemia, Refractory, with Excess of Blasts in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berz, D; Cassidy, HM; Connell, NT; Winer, ES | 1 |
Urabe, A | 1 |
Kusakabe, K; Mizoguchi, H; Motoji, T; Okada, M; Oshimi, K; Takahashi, M; Teramura, M | 1 |
1 review(s) available for methylprednisolone and Anemia, Refractory, with Excess of Blasts
Article | Year |
---|---|
[Myelodysplastic syndrome].
Topics: Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Antilymphocyte Serum; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes; Prognosis; World Health Organization | 2005 |
2 other study(ies) available for methylprednisolone and Anemia, Refractory, with Excess of Blasts
Article | Year |
---|---|
Alphabet soup: RAEB, HMA, DOE, and AFOP.
Topics: Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Azacitidine; Biopsy; Bronchoscopy; Cryptogenic Organizing Pneumonia; Decitabine; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Heart Transplantation; Humans; Male; Methylprednisolone; Middle Aged; Pulmonary Fibrosis; Tomography, X-Ray Computed | 2010 |
Successful treatment of refractory anemia with high-dose methylprednisolone.
Topics: Adult; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Dose-Response Relationship, Drug; Female; Humans; Karyotyping; Male; Methylprednisolone | 1990 |